Aurora Cannabis Inc.
As of Oct 22, 2026, Aurora Cannabis is in Stage 2, the uptrend phase, now in week 4 (since Sep 30, 2026). It closed at $3.97, 28.7% below its 52-week high and above its 200-day average, which is falling.
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 26 in Drug Manufacturers - Specialty & Generic · #1 of 272 in Health Care
Is ACB early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
ACB among Drug Manufacturers - Specialty & Generic44th of 84 by relative strength
All 84 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CPIX | Stage 2 · wk 23 | 98 | +6.8% |
| 2 | ETON | Stage 2 · wk 30 | 97 | −10.1% |
| 3 | ANIK | Stage 2 · wk 15 | 96 | +3.5% |
| 4 | IRWD | Stage 3 · wk 3 | 96 | −16.4% |
| 5 | TEVA | Stage 2 · wk 9 | 95 | +3.1% |
| 6 | AMRX | Stage 2 · wk 19 | 95 | +5.9% |
| 7 | KNSA | Stage 2 · wk 73 | 95 | +6.2% |
| 8 | AMLX | Stage 2 · wk 15 | 93 | −6.6% |
| …44 | ACB | Stage 2 · wk 4 | 38 | −5.9% |
Aurora Cannabis: quick answers
What stage is Aurora Cannabis in?
As of Oct 22, 2026, Aurora Cannabis (ACB) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 30, 2026 and is in week 4. What the four stages mean
Is Aurora Cannabis in an uptrend?
Yes. Aurora Cannabis is in a Stage 2 uptrend. It trades 11.9% above its 200-day average, which is falling.
How far is Aurora Cannabis from its 52-week high?
Aurora Cannabis closed at $3.97 on Oct 22, 2026, 28.7% below its 52-week high of $5.57. Its 52-week low is $2.58.
How has Aurora Cannabis performed over the past year?
As of Oct 22, 2026, Aurora Cannabis is down 22.8% over the past year and down 8.5% so far in 2026.
Which sector and industry is Aurora Cannabis in?
Aurora Cannabis is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.
About this companyHealth Care· Drug Manufacturers - Specialty & Generic
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.